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Abstract
Background: Cardiovascular disease is the most common cause of death worldwide. In order to prevent and treat heart dis-
eases, we need to estimate the trend of non-cardiac diseases with the cardiovascular system. Arthritis Rheumatoid is a chronic 
immune/inflammatory process which leads to subclinical atherosclerosis and increases cardiovascular disease. We examined 
the patients who referred to our nuclear medicine center for MPI and correlated their findings with flow-mediated dilatation 
(FMD) of the brachial artery and carotid intima-media thickness (CIMT) in arthritis rheumatoid patients.
Material and methods: A total 30 known cases with arthritis rheumatoid were referred to our department for MPI and the 
single-photon emission computed tomography (SPECT) imaging were visually and quantitatively evaluated by two nuclear 
medicine physicians and the correlation of the measured FMD and CIMT were evaluated and compared with ultrasonography 
data. Demographic information such as gender, age and sex and medical history (risk factors, cardiovascular sign and symp-
toms, lab findings, medication etc…) were recorded in questionnaire sheets and were analyzed by SPSS.20. Chi-square and 
student t-test were used for further analysis.
Results: The mean CIMT (R = 0.452 ± 0.07, L = 0.447 ± 0.08) and %FMD (R = 7.22 ± 8.66, L = 6.42 ± 11.88) were 
measured for all subjects. Age was the only parameter correlated with both right and left CIMT (P = 0.033 and P = 0.024, 
respectively). Among the patients, 26.7% had mild ischemia (SSS < 8) and 3 of them suffered from active arthritis rheumatoid. 
All patients with RA showed normal ventricular ejection fraction and normal volumes and among them, 93.3% had normal 
functional performance (normal wall motion…). Moreover, the mean CIMT and %FMD were not significantly different in ischemic 
and non-ischemic patients. Among ischemic patients, just the course of the disease was associated with CIMT and none of 
the parameters was correlated with FMD.
Conclusions: There is no significant statistical difference between ischemic and non-ischemic patients and also the functional 
performance with values of CIMT and FMD. Among all populations, the parameter of age, and in ischemic group, the course 
of disease were found as the only variable correlated with CIMT.
KEY words: brachial artery, flow-mediated dilatation, intima-media thickness, myocardial perfusion imaging, rheumatoid 
arthritis, gated SPECT, myocardial ischemia
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Background
Rheumatoid arthritis (RA) is a systemic chronic inflammatory 
disease with a global prevalence of 1–2% [1]. It is reported that 
RA has increased risk of cardiovascular events that are not fully 
explained by other classic cardiovascular risk factors. To that end, 
the relationship between RA, atherosclerosis and cardiovascular 
events is a controversial topic. RA and atherosclerosis share several 
pathomechanisms including inflammation [2]. The bold complaint 
of RA is joints involvement, however; atherosclerotic cardiovascular 
disease (CVD) is the main cause of morbidity and mortality in these 
patients. Therefore, an increased risk of CVD occurs even during 
the initial period of RA, hence; it may be considered as a possible 
clinical manifestation of the disease. Accordingly, it is necessary 
to achieve a correct understanding of the pathomechanisms com-
monly associated with the risks of both diseases to treat RA, reduce 
atherosclerosis and its subsequent effects on cardiovascular dis-
ease in these patients [2]. Patients with RA are more susceptible to 
myocardial infarction (2 to 3 folds), congestive heart failure (2 folds), 
sudden death (2 folds) and stroke (1.7 folds) [3]. 
The presence of chronic inflammatory immune process-
es leads to subclinical atherosclerosis and increases the incidence 
of cardiovascular events in these patients. The severity and chronic-
ity of immune responses are directly related to atherosclerotic dis-
eases in patients with RA [4, 5]. Inflammation-induced endothelial 
dysfunction causes early autogenesis onset and also it is associ-
ated with clinical manifestations of vascular disease including the 
progression of atherosclerotic plaque in late stages [6]. 
Atherosclerosis is a systemic process, endothelial dysfunction 
can be monitored in the peripheral circulation and the coronary 
system [7, 8]. Ultrasound examination of the flow-mediated dilation 
(FMD) after brachial artery occlusion is a physiological non-invasive 
technique for the evaluation of endothelial function [9, 10]. In 
this method, FMD is an endothelial response to stress caused by 
reactive hyperemia [10].
Ultrasound-based carotid intima-media thickness test (CIMT) 
is a non-invasive anatomical method for evaluation of subclinical 
atherosclerosis (without clinical evidence of atherosclerosis, such 
as cardiovascular disease, peripheral vascular diseases, etc.) 
[11]. This method is an excellent indicator of the large arteries ath-
erosclerosis and the most common method for the study of early 
structural changes in the artery walls. A number of studies showed 
that CIMT was significantly higher in patients with RA than in the 
control group [12]. 
Atherosclerosis affects the arteries which lead to stenosis, ob-
struction and ultimately ischemic heart disease. Having that said, 
atherosclerotic indices are normally more severe in patients with 
ischemic heart disease than those without myocardial ischemia. 
It is noteworthy that if myocardial ischemia is diagnosed before 
the incidence of the clinically apparent disease the application of 
ultrasound (a non-invasive technique) to screen patients at risk 
of ischemic heart disease, can be replaced with more invasive 
methods such as angiography.
Therefore, in this study, we assessed the myocardial perfusion 
and function with gated SPECT, and CIMT and FMD in the brachial 
artery by using ultrasound in patients with RA. Then, we evaluated 
the relationship of these findings with myocardial ischemia and 
dysfunction in these patients.
Material and methods
Study participants
The present study is a descriptive cross-sectional study that 
was performed on 30 patients (20 to 60 years old) with a definitive 
diagnosis of RA, based on the clinical and laboratory tests (new 
2010 ACR-EULAR criteria). A non-randomized sampling method 
was used on patients with a proven diagnosis of RA. The study 
was performed according to the World Medical Association Declara-
tion of Helsinki and approved by local ethics committees.
One of the inclusion criteria is the passage of three years from 
the onset of the disease and receiving the classic drug for the 
treatment of RA. Patients were excluded from the study if they 
had metabolic diseases such as diabetes, hyperlipidemia, and 
hypertension, history of ischemic heart disease, atherosclerotic 
lesions, dysplastic vascular diseases, smoking and other rheu-
matic diseases. 
After considering the inclusion and exclusion criteria, a ques-
tionnaire was separately completed for each individual including 
the information on gender, age, duration of disease, disease 
activity score (DAS), C-reactive protein (CRP), ESR, systolic blood 
pressure, high-density lipoprotein cholesterol (HDL-C), low-density 
lipoprotein cholesterol (LDL-C).
Ultrasound
All ultrasonographic tests were performed by a radiologist 
with 10 years’ experience of ultrasound assessment using a 12.5 
MHz linear probe device (G50, Affiniti, PHILIPS, USA). To measure 
CIMT, the patient was placed in the supine position. The neck 
was stretched out and the face was fixed to the opposite side. Both 
carotid arteries were examined in both transverse and longitudinal 
views. CIMT was measured in the wall of the carotid artery common 
to each side 1–2 cm close to the bulb at three points and in the clos-
est part of the carotid artery of each side, in the vicinity of its origin at 
three points and the mean of the three points was recorded in each 
side. This measurement was performed on both sides and the total 
thickness of the intima carotid artery was measured at four levels. 
The brachial artery was studied in the supine position, after 
a ten minutes rest, from a vein that lacks permanent vascular ac-
cess. First, the brachial artery size was measured in a 5–10 cm 
longitudinal scan above the antecubital fossa. The luminal size 
of the near and far wall IMT was determined. After recording the 
base size of the artery (D0), the temporary ischemia was created by 
a cuff placed around the arm. The cuff was filled up to 200 mm Hg 
or 50 mm Hg above the systolic blood pressure for 5 minutes and 
then discharged and the second scan was measured 40 to 60 sec-
onds after emptying the cuff. FMD was calculated as the percentage 
of change in the post-ischemia luminal size of the artery compared 
to the base and calculated by the formula (D1–D0 / D0 × 100). 
Image Acquisition and Processing
 Patients were referred to the heart hospital for myocardial 
perfusion imaging (MPI) to investigate the presence or absence of 
ischemic and the functional performance. All patients were injected 
the standard dose (555 MBq) of 99mTc-MIBI after pharmacological 
stress test (according to the predefined standard Dipyridamole 
protocol). The same amount of 99mTc-MIBI was administered to ac-
quire the rest phase data on the following day. All the images were 
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acquired 45–60 minutes post-injection. The patients were laid in 
supine position and imaging was performed with a dual-headed 
SPECT gamma camera (E-cam; SIEMENS) in a 90° orientation with 
a low energy high resolution (LEHR) collimators in a 180° angle from 
RAO to LPO. The images were acquired in the tomographic mode 
(SPECT), thirty-two 30-second projection images with a 64 × 64 ma-
trix size in a step-and-shoot mode and zoom factor of 1.45. 
 All the images were read by two nuclear medicine physicians. 
The scans were all evaluated in both visual and quantitative meth-
ods using Cedars QGS/QPS (Cedars-Sinai Medical Center). The 
findings of this study were recorded in a questionnaire designed 
for this purpose. 
Finally, the results were analyzed using SPSS for windows ver-
sion 20.0 (IMB SPSS Statistics, USA). Descriptive data are ex-
pressed as mean and standard deviation, and student’s t-test 
was used for quantitative variables and chi-square test for qualita-
tive variables. The P values of lower than 0.05 were considered 
significant.
Results
In this study, a total of 30 patients including 29 females (96.7%) 
and 1 male (3.3%) with RA were recruited within 9 months. 
Twenty-five patients (83.3%) were housewives and others were 
employed. Positive and negative CRP results were seen in 8 (26.7%) 
and 22 patients (73.3%) with RA. According to the DAS, 19 (63.3%) 
and 11 patients (36.7%) suffered from inactive and active RA dis-
ease, respectively. The mean course of the disease was 5.52 ± 4.55 
years. A summary of the demographic data and the common risk 
factors for their cardiovascular diseases are presented in Table 1. 
Ultrasound findings
The mean of left and right CIMT were 0.458 ± 0.081 mm and 
0.461 ± 0.106 mm, respectively. Also, the thickness of the right and 
left internal carotid arteries were calculated 0.446 ± 0.086 mm and 
0.434 ± 0.07 mm, respectively. The FMD percentage was calculated 
7.22 ± 8.66 and 6.42 ± 11.88 in the right and left brachial artery 
(Tab. 2).
In this study, Pearson and/or Spearman correlations test were 
used to examine the inter-variable correlation for each parameter 
(Tab. 3). The findings did not show any correlation between IMT 
and FMD in patients with RA (p > 0.05). 
Nuclear medicine scan findings
Myocardial perfusion scan was performed to assess the cardiac 
functional indexes, the presence or absence of stress induced 
ischemia, the extent of ischemia and the intended ischemic region. 
To survey the ischemia and its severity, among 30 patients with RA, 
8 of them (26.7%) suffered from mild ischemia while 22 (73.3%) 
patients possessed normal MPI. 
In addition, the comparison of measured parameters in indi-
viduals with and without ischemia showed that only the high sys-
tolic blood pressure in an asymptomatic cardiac ischemic group 
was close to the significant level (p = 0.074) and there was no 
significant difference between the two groups in terms of other 
parameters (Tab. 4). 
Among 8 patients with ischemia, 5 (62.5%) of them had inactive 
RA, the remaining 3 (37.5%) patients had active RA; however, in 
non-ischemic subjects, these ratios were 14 (63.7%) and 8 (36.3%), 
respectively. There was no significant difference between the two 
groups in terms of disease activity score (p = 0.976). CRP test 
was positive for 3 ischemic and 5 non-ischemic patients (p = 0.418). 
There was no significant relationship between the two groups of 
ischemic and non-ischemic RA patients in terms of mean CIMT in all 
four levels and the percentage of FMD in the right and left brachial 
artery (Tab. 5). Pearson’s correlation test was used to investigate 
the relationship between IMT and risk factors among 8 patients with 
and without inducible ischemia and the results showed a sig-
nificant positive correlation between age and IMT in right CCA1 
(p = 0.057) and left ICA2 (p = 0.038) and a significant inclination 
in right ICA (p = 0.095). Moreover, a significant positive correlation 
was observed between the course of the disease and IMT in all four 
levels in RA ischemic patients (p < 0.05) (Tab. 6). Except for two 
patients (6.7%) with hypokinesia of septal wall, there is a normal 
1common carotid artery 
2internal carotid artery 
Table 1. Demographic and clinical data regarding common 
cardiovascular risk factors in all patients with rheumatoid arthritis
Mean ± SDMeasured parameters
45.23 ± 9.09Age
117.33 ± 9.16Systolic blood pressure (mm Hg)
79 ± 4.02Diastolic blood pressure (mm Hg)
6.52 ± 4.55Course disease (Year)
20.8 ± 14.25ESR (mm/h)
128.1 ± 25.17LDL (mg/dL)
46.17 ± 9.09HDL (mg/dL)
Table 2. Mean intima-media thickness of carotid arteries and flow-
mediated dilatation in the brachial artery in all patients with rheumatoid 
arthritis
Measured parameters Mean ± SD
Mean Intima-media  
thickness (mm)
Right CCA 0.458 ± 0.081
Left CCA 0.461 ± 0.106
Total CCA 0.46 ± 0.087
Right ICA 0.446 ± 0.086
Left ICA 0.434 ± 0.07
Total ICA 0.440 ± 0.071
Diameter (mm) Baseline Right BA 3.513 ± 0.47
Left BA 3.540 ± 0.41
After 
ischemia
Right BA 3.75 ± 0.46
Left BA 3.75 ± 0.47
Flow-mediated 
dilatation (%)
Right BA 7.22 ± 8.66
Left BA 6.42 ± 11.88
Total BA 6.82 ± 7.38
CCA — common carotid artery, ICA — internal carotid artery, BA — brachial artery
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Table 4. Comparison of mean demographic and cardiovascular risk factors in patients with and without ischemic heart disease
Measured parameters Ischemic patients Non-ischemic patients P-value
Age (year) 43.62 ± 10.79 45.82 ± 8.6 0.568
Systolic blood pressure (mm Hg) 121.88 ± 6.51 115.68 ± 9.54 0.074
Diastolic blood pressure (mm Hg) 80 ± 0.0 78.64 ± 4.67 0.597
Course disease (Year) 5.75 ± 2.25 6.8 ± 5.15 0.587
ESR 23.62 ± 15.99 19.77 ± 13.82 0.522
LDL 129.71 ± 16.76 127.59 ± 27.63 0.850
HDL 44.71 ± 3.30 46.64 ± 10.30 0.635
Table 3. Correlation of main clinical parameters with IMT of CCA, RCA and FMD of BA in all patients with rheumatoid arthritis
CCA - R CCA- L ICA - R ICA- L FMD - R FMD - L
r P r P r P r P r P r P
Age 0.342 0.064 0.304 0.102 0.280 0.125 0.254 0.175 -0.101 0.594 -0.295 0.112
Systolic blood 
pressure (mm Hg)
0.186 0.326 -0.127 0.503 0.017 0.928 -0.073 0.702 -0.014 0.943 -0.092 0.627
Diastolic blood 
pressure (mm Hg)
0.080 0.674 -0.254 0.176 0.072 0.704 -0.113 0.550 -0.005 0.981 -0.080 0.674
Course disease 
(Year)
-0.041 0.829 -0.072 0.706 -0.031 0.870 -0.014 0.942 -0.300 0.107 -0.036 0.851
Activity disease 0.026 0.893 -0.042 0.831 0.084 0.665 -0.057 0.768 0.152 0.431 -0.019 0.922
ESR 0.082 0.666 -0.078 0.680 0.091 0.631 -0.095 0.618 0.068 0.720 -0.088 0.643
CRP -0.067 0.727 -0.135 0.475 0.112 0.557 -0.219 0.244 -0.120 0.529 -0.043 0.823
LDL -0.297 0.118 -0.030 0.877 0.046 0.811 -0.170 0.378 0.175 0.363 0.146 0.451
HDL -0.013 0.947 -0.128 0.509 -0.080 0.680 0.127 0.510 -0.088 0.648 0.152 0.431
CCA — common carotid artery, ICA — internal carotid artery, FMD — flow mediated dilatation, R — right, L — left
Table 5. Comparison of mean CIMT and BA FMD in patients with and without ischemic heart disease
Measured parameters Ischemic patients Non-ischemic patients P-value
Mean Intima-media 
thickness (mm)
Right CCA 0.483 ± 0.10 0.450 ± 0.07 0.333
Left CCA 0.462 ±0.10 0.458 ± 0.12 0.933
Total CCA 0.483 ±0.10 0.450 ± 0.07 0.333
Right ICA 0.448 ±0.08 0.441 ± 0.09 0.853
Left ICA 0.433 ± 0.10 0.434 ± 0.05 0.961
Total ICA 0.470 ± 0.11 0.456 ± 0.07 0.689
Diameter (mm) Baseline Right BA 0.441 ± 0.06 0.437 ± 0.09 0.891
Left BA 3.70 ± 0.40 3.48 ± 0.41 0.210
After ischemia Right BA 3.67 ± 0.53 3.77 ± 0.44 0.601
Left BA 3.88 ± 0.49 3.70 ± 0.46 0.342
Flow-mediated dilatation (%) Right BA 5.91 ± 7.40 7.69 ± 9.18 0.626
Left BA 5.14 ± 7.4 6.88 ± 13.26 0.730
Total BA 86.48 ± 10.8 6.21 ± 5.90 0.913
CCA — common carotid artery, ICA — internal carotid artery, BA — brachial artery
systolic and diastolic function and volumes in the rest of these 
patients.
Discussion 
The ultrasound-based measurement of the FMD of peripheral 
arteries and IMT of the carotid artery is a non-invasive technique 
for the diagnosis of atherosclerosis in patients with RA [13]. Our 
study showed, RA patients possess higher carotid arteries IMT and 
lower brachial artery FMD in comparison with in control subjects. 
So far, there are several reports from different countries about 
the prevalence of subclinical atherosclerosis in patients with RA. 
Most of these studies focused on long-standing and a few of them 
[13, 14] concentrated on early stages (less than 12 months old) 
of RA in the subjects. Some studies investigated both IMT and 
FMD markers while others studied only IMTs to predict subclinical 
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atherosclerosis. However, these studies pointed out the importance 
of IMT and FMD determination as a useful tool to assess the risk 
of cardiovascular disease as the most common cause of mortality 
in RA patients. 
In this, we measured IMT in two levels (common and internal 
carotid artery) at four points (on both sides of the body) which is the 
advantage of this study in comparison with others. Some stud-
ies failed to prove increased IMT in patients with RA in comparison 
controls; having that said, this design aimed to provide a more ac-
curate comparison while reducing the effect of the error. Besides, 
the present study was the comparison of these two markers in two 
subgroups of RA patients with and without silent cardiac ischemia 
confirmed by a cardiac perfusion scan. 
According to our findings, the mean IMT on both sides of the 
CCA and ICA were 0.460 ± 0.67 mm and 0.440 ± 0.071 mm, 
respectively. To that end, Ristic et al. performed a study to com-
pare women with long-term RA and the same age-matched 
healthy control group. They reported a higher value for carotid 
IMT in patients with RA than the control group in all measured 
positions [15]. The mean CCA of both sides in patients with RA 
was 0.671 ± 0.119 mm, which was significantly greater, compared 
to the control subjects (0.621 ± 0.085) and the mean ICA in the 
RA group was 0.577 ± 0.10 mm and 0.535 ± 0.076 mm in the 
control group. 
Ristic et al. performed a study which the mean of age was close 
to ours (45.3 ± 0.10 compared to 45.23 ± 9.09 years), even though 
their reported average course of the disease was slightly higher 
than ours (7.1 ± 5.4 compared to 5.52 ± 4.55 years). Therefore, 
it can be stated that the lower values of IMT in our study may be 
due to the high number of participants in the early stages of the 
disease and the lower course of the disease (less than 5 years).
 Articles that have reviewed patients with long-standing RA, 
reported higher IMT values than the present study [16–18]. However, 
Adhikari et al. study which was performed on a group of people 
with early stages of rheumatoid arthritis (less than 12 months old), 
reported IMT values very close to our study [13]. 
There are many discussions about the risk of developing 
CVD and the course of the disease. For example, in the study 
on the health of nurses, scientists have posed the possibility of 
an increased risk of cardiovascular disease only in patients with 
a disease course for more than 10 years. Del Ricon et al. stated 
that the effect of the disease course was only significant after the 
age of 60 [4], whereas people under the age of 60 participated 
in our study. Some also mentioned more invasive rheumatoid 
arthritis treatments as a reason for no relationship between IMT 
values and the course of the disease.
Adhikari et al. reported mean values for FMD are very close 
to our study (6.82 ± 7.38%). In this study, the FMD value in pa-
tients with RA (5.26%) was significantly lower than that of the control 
group (10.34%) (p = 0.004) [13]. Fan et al. also found that the per-
centage of FMD of the brachial artery in patients (5.45% ± 2.65%) 
is significantly lower than that of the control group (8.47% ± 2.85%) 
(p < 0.001) [17]. 
Overall, the scientists showed a higher IMT of carotid arter-
ies and lower FMD of the brachial artery in patients with RA than 
the control group, indicating subclinical atherosclerosis in these 
patients [19, 20]. These results are very important in evaluating 
the cardiovascular outcomes and suggest alternative subclinical 
atherosclerosis markers that can predict the risk of cardiovascular 
diseases, especially the incidence of this disease in these patients. 
However, these studies did not investigate the predictive power 
of these markers in certain cases of cardiovascular diseases, 
especially silent myocardial ischemia, which is highly prevalent in 
these patients.
In our study, when patients were compared to investigate the 
presence of inducible ischemia using nuclear medicine imag-
ing, 8 patients (26.7%) had mild ischemia. Although the mean 
IMT of the common and internal carotid artery in the ischemic 
group (0.470 ± 0.11 mm and 0.441 ± 0.06 mm, respectively) 
was higher than that of the non-ischemic group (0.456 ± 0.07 mm, 
0.437 ± 0.09 mm, respectively), but this difference was not statisti-
cally significant.
Carlos Gonzalez-Juanatey et al. studied the effect of carotid IMT 
in predicting cardiovascular diseases, including silent myocardial 
ischemia, and found that only 9% of patients had stress induced 
ischemia [16]. Among the studied clinical factors, there was a sig-
nificant difference only in the cardiovascular disease group with old 
patients. Among the ultrasound markers, the higher carotid IMT and 
the number of patients with carotid plaque were more significant. 
In their study, only the IMT value of the right common carotid artery 
Table 6. Correlation of main clinical parameters with IMT of CCA, RCA and FMD of BA in rheumatoid arthritis patients with ischemic heart disease 
CCA - R CCA- L ICA - R ICA- L FMD – R FMD - L
r P r P r P r P r P r P
Age 0.693 0.057 0.594 0.121 0.628 0.095 0.735 0.038 -0.110 0.795 -0.543 0.164
Systolic blood 
pressure (mm Hg)
0.682 0.062 0.614 0.105 0.374 0.361 0.333 0.420 -0.086 0.839 0.199 0.839 
Course disease 
(Year)
0.905 0.002* 0.858 0.006* 0.877 0.004* 0.809 0.015* 0.094 0.825 -0.128 0.763
Activity disease -0.126 0.767 -0.231 0.582 -0.076 0.857 -0.335 0.417 -0.019 0.964 0.367 0.330
ESR 0.150 0.722 -0.009 0.984 0.042 0.921 -0.195 0.643 0.158 0.709 0.337 0.415
CRP -0.126 0.767 -0.231 0.582 -0.076 0.857 -0.335 0.417 -0.019 0.966 0.397 0.330
LDL 0.002 0.996 -0.186 0.690 -0.134 0.775 -0.420 0.348 0.277 0.548 0.677 0.095
HDL -0.332 0.467 -0.257 0.578 -0.318 0.487 -0.490 0.264 0.477 0.278 0.703 0.078
CCA — common carotid artery, ICA — internal carotid artery, FMD — flow mediated dilatation, R — right, L — left 
Nuclear Medicine Review 2020, Vol. 23, No. 1
www.journals.viamedica.pl/nuclear_medicine_review30
Original
was measured which was 1.01 ± 0.16 and 0.74 ± 0.12 mm Hg 
in patients with and without cardiovascular diseases, respectively 
[16]. However, in our study, the mean IMT of the right carotid artery 
was 0.483 ± 0.10 mm and 0.450 ± 0.07 mm in patients with and 
without ischemia, respectively. in contrast to Gonzales-Juanatey et 
al., we found no statistically significant relationship.
One of the reasons for this difference is the higher age of 
the Gonzales_Juanatey et al. patients, considering the fact that 
atherosclerosis is a chronic process strongly associated with 
age, this difference is reasonable. Longer disease course can 
be accounted for as another factor in their study. The course of 
RA disease for Gonzales_Juanatey et al. patients was 20.5 ± 5.9 
(patients with CVD) and 21.2 ± 8.8 (patients without CVD) years; 
however, in our study, the course of the disease was 5.75 ± 2.25 
(patients with myocardial ischemia) and 6.8 ± 5.15 (patients without 
myocardial ischemia) years. 
Interestingly, Gonzales-Juanatey et al. observed that none of 
the subjects with IMT less than 0.77 mm suffer from cardiovascular 
disease, and 6 out of 10 patients with carotid IMT greater than 
0.91 mm cardiovascular disease was part of the group with CVD 
[16]. In the present study, the diagnosis of ischemia, despite the 
mean IMT of less than 0.77 mm in people with inducible ischemia, 
may be indicative of a higher detection power and a higher sensitiv-
ity of the nuclear medicine imaging in the diagnosis of myocardial 
ischemia; science, Gonzales-Juanatey et al. diagnosed ischemia 
using electrocardiography [16]. 
In the present study, when the relationship between the com-
mon risk factors of atherosclerogenesis with IMT and FMD were 
examined, a correlation between age and IMT was observed only 
in the right CCA position. In different studies, Fan et al. [17], Amin 
et al. [19] and Adhikari et al. [13] found a positive correlation be-
tween the age and magnitude of IMT of the common carotid artery.
 When the correlation between common risk factors of cardio-
vascular disease, IMT and FMD in the subgroup of silent ischemia 
was studied, a significant positive correlation between age and 
IMT was found in the right CCA and left ICA and the tendency 
of a significant correlation in the right ICA. In a study conducted 
by Gonzales et al., after examining the models that measure the 
effect of various risk factors on the progression of carotid IMT 
and incidence of cardiovascular disease, it was found that age 
has an independent larger or similar effect with other risk factors for 
cardiovascular disease such as hypertension or dyslipidemia 
[9]. Also, there was a significant positive correlation between the 
course of the disease and IMT in all four levels of ischemia in pa-
tients with RA. The course of RA is considered as a risk factor for 
the early onset of atherosclerosis, but similar studies have shown 
contradictory findings. 
 Contrary to the fact that serum lipids are a strong predictor 
of atherosclerogenesis, our study did not show any correlation 
between IMT and lipid levels, which is in agreement with Ristic 
et al. reported results [15]. Chronic inflammation, which is the 
main characteristic of rheumatoid arthritis, plays a major role 
in exacerbating atherosclerosis [15]. In our study, there was no 
correlation between IMT and inflammatory markers of ESR and 
CRP. Likewise, Ristic et al. [15] and Gonzalez-Gay et al. [5], failed 
to demonstrate this correlation, while Fan et al. [17] and Amin 
et al. [19] found a significant correlation between IMT and CRP. 
The possible explanation for this result is that the exacerbation of 
atherosclerosis depends on the cumulative effect of prolonged 
inflammation. Therefore, measuring inflammatory markers at 
a single time point may not be related to IMT [15]. This finding 
was confirmed by studies conducted in Japan which showed 
that the effect of inflammation was more accurately detected in 
longitudinal than in cross-sectional studies [21, 22]. 
Some limitations of the present study include the inadequate 
number of participants and the absence of a control group due to 
the need to perform a myocardial perfusion scan for all patients.
Conclusions
In the present study, although there was no significant difference 
between the group with inducible ischemia and without inducible 
ischemia and no relationship between functional indexes and vari-
ous values of subclinical atherosclerosis indices (IMT and FMD). it 
is noteworthy that the higher IMT values in patients with inducible 
ischemia and its relation with age and course of the disease showed 
the need for larger and wider studies to suggest ultrasound as a tool 
for screening people with rheumatoid arthritis at risk of ischemia.
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